Individual versus standard dose of rFSH in a mild stimulation protocol for intrauterine insemination: A randomized study

Human Reproduction

Volumn 24, Issue 10, 2009, Pages 2523-2530

  La Cour Freiesleben, N ^a   Lossl, K ^a   Bogstad, J ^b   Bredkjaer H E ^c   Toft, B ^d   Rosendahl, M ^a   Loft, A ^a   Bangsboll, S ^a   Pinborg, A ^a   Nyboe Andersen, A ^a  

^a University of Copenhagen   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c HOLBÆK HOSPITAL   (Denmark)

^d HORSENS REGIONAL HOSPITAL   (Denmark)

Author keywords

Controlled ovarian stimulation; Dosage nomogram; Individual dosing; IUI; Ovarian response

Indexed keywords

CHORIONIC GONADOTROPIN; GANIRELIX; RECOMBINANT FOLLITROPIN;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BODY WEIGHT; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED OVARY STIMULATION; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY THERAPY; INTRAUTERINE INSEMINATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NOMOGRAM; OVARY FOLLICLE; OVARY HYPERSTIMULATION; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL;

ADULT; BODY WEIGHT; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HORMONES; HUMANS; INSEMINATION, ARTIFICIAL; NOMOGRAMS; OVARY; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RECOMBINANT PROTEINS;

EID: 70349451745     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dep239     Document Type: Article

References (20)

1. American Society for Reproductive Medicine (ASRM). Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997;67:817-821.
2. Danish Fertility Society. Guideline 12: Indikationer for in vitro fertilisering (IVF) og mikroinsemination (ICSI). www.fertilitetsselskab.dk (2006, date last accessed).
3. Fauser BCJM, Diedrich K, Devroey P, on behalf of the Evian Annual Reproduction (EVAR) Workshop Group 2007.Predictors of ovarian response: Progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum Reprod Update 2008;14:1-14.
4. Freiesleben NC, Lossl K, Bogstad J, Bredkjær HE, Toft B, Loft A, Bangsboll S, Pinborg A, Budtz-Jørgensen E, Nyboe Andersen A. Predictors of ovarian response in intrauterine insemination patients and development of a dosage nomogram. Reprod Biomed Online 2008; 17:632-641.
5. Goverde AJ, McDonnell J, Vermeiden JPW, Schats R, Rutten FFH, Schoemaker J. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: A randomised trial and cost-effectiveness analysis. Lancet 2000;355:13-18.
6. Goverde AJ, Lambalk CB, McDonnell J, Schats R, Homburg R, Vermeiden JPW. Further considerations on natural or mild hyperstimulation cycles for intrauterine insemination treatment: Effects on pregnancy and multiple pregnancy rates. Hum Reprod 2005;20:3141-3146.
7. Hohmann FP, Macklon NS, Fauser BCJM. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endocrinol Metab 2003;88:166-173.
8. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 1999;319:670-674.
9. Karande VC, Korn A, Morris R, Rao R, Balin M, Rinehart J, Dohn K, Gleicher N. Prospective randomized trial comparing the outcome and cost of in vitro fertilization with that of a traditional treatment algorithm as first-line therapy for couples with infertility. Fertil Steril 1999; 71:468-475.
10. Lambalk CB, Leader A, Olivennes F, Fluker MR, Nyboe Andersen A, Ingerslev J, Khalaf Y, Avril C, Belaisch-Allart J, Roulier R et al. Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: Results of a double-blind, placebo-controlled, multicentre trial. Hum Reprod 2006;21:632-639.
11. Matorras R, Ramón O, Expó sito A, Corcó stegui B, Ocerin I, Gonzalez-Lopera S, Rodrýguez-Escudero FJ. Gn-RH antagonists in intrauterine insemination: The weekend-free protocol. J Assist Reprod Genet 2006;23:51-54. (Pubitemid 43828707)
12. National Collaborating Centre for Women's and Children's Health. Assessment and treatment for people with fertility problems. CG11 Fertility: Algorithm. wwwfinice.org.uk (2004, date last accessed).
13. Nyboe Andersen A, Balen A, Platteau P, Devroey P, Helmgaard L, Arce JC, for the Bravelle Ovulation Induction (BOI) Study Group. Predicting the FSH threshold dose in women with WHO Group II anovulatory infertility failing to ovulate or conceive on clomiphene citrate. Hum Reprod 2008;23:1424-1430.
14. Popovic-Todorovic B, Loft A, Lindhard A, Bangsbøll S, Andersson AM, Nyboe Andersen A. A prospective study of predictive factors of ovarian response in 'standard' IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram. Hum Reprod 2003a;18:781-787.
15. Popovic-Todorovic B, Loft A, Ejdrup Bredkjæer H, Bangsbøll S, Nielsen IK, Nyboe Andersen A. A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment. Hum Reprod 2003b;18:2275-2282.
16. Ragni G, Alagna F, Brigante C, Riccaboni A, Colombo M, Somigliana E, Crosignani PG. GnRH antagonists and mild ovarian stimulation for intrauterine insemination: A randomized study comparing different gonadotrophin dosages. Hum Reprod 2004;19:54-58.
17. Steures P, Berkhout JC, Hompes PGA, van der Steeg JW, Bossuyt PMM, van der Veen F, Habbema JCF, Eijkemans MJC, Mol BWJ. Patients' preferences in deciding between intrauterine insemination and expectant management. Hum Reprod 2005;20:752-755.
18. Steures P, van der Steeg JW, Hompes PGA, Habbema JDF, Eijkemans MJC, Broekmans FJ, Verhoeve HR, Bossuyt PMM, van der Veen F, Mol BWJ, for the Collaborative Effort on the Clinical Evaluation in Reproductive Medicine. Intrauterine insemination with controlled ovarian hyperstimulation versus expectant management for couples with unexplained subfertility and an intermediate prognosis: A randomised clinical trial. Lancet 2006;368:216-221.
19. van Rumste MME, Custers IM, van der Veen F, van Wely M, Evers JLH, Mol BWJ. The Influence of the number of follicles on pregnancy rates in intrauterine insemination with ovarian stimulation: A meta-analysis. Hum Reprod Update 2008;14:563-570.
20. Verberg MFG, Eijkemans MJC, Macklon NS, Heijnen EMEW, Baart EB, Hohmann FP, Fauser BCJM, Broekmans FJ. The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: A meta-analysis. Hum Reprod Update 2009;15:5-12.